Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q3 FY2018
As of Sep 30, 2018
Q2 FY2018
As of Jun 30, 2018
Q1 FY2018
As of Mar 31, 2018
Q4 FY2017
As of Dec 31, 2017
Q3 FY2017
As of Sep 30, 2017
Q2 FY2017
As of Jun 30, 2017
Q1 FY2017
As of Mar 31, 2017
Q4 FY2016
As of Dec 31, 2016
Q3 FY2016
As of Sep 30, 2016
Cash and cash equivalents
Short-term investments
Accounts receivable, net
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Intangible assets
Right-of-use assets, net
Other assets
Total assets
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable
Accrued compensation
Accrued legal settlement
Other accrued liabilities
Short-term lease liability
Short-term deferred revenue
Total current liabilities
Long-term deferred revenue
Other long-term liabilities
Total liabilities
Stockholders' equity:
Common stock; par value $0.0001, 50,000 shares authorized; 24,572 issued and 24,220 outstanding at June 30, 2021 and 19,973 issued and 19,490 outstanding at December 31, 2020
Additional paid-in capital
Treasury stock, at cost (483 shares at March 31, 2021 and December 31, 2020)
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders' equity
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support